Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

1(33.3%)

N/A

1(33.3%)

Phase 1

1(33.3%)

3Total

Phase 4(1)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT05381961Unknown

Observational Study of BIS in Hemodialysis Patients

Role: collaborator

NCT03438773Phase 1Unknown

Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

Role: lead

NCT04633304Not ApplicableUnknown

A Single Arm sTudy to Evaluate the Effectiveness of EndoAVF in a Pre-dialysis Population (STEP Study)

Role: lead

NCT02106962Phase 4Completed

Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients

Role: lead

All 4 trials loaded